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ABSTRACT
Medulloblastoma is the most common childhood malignant tumor of central nervous 
system, but it may also occur in adults. It presents high invasive growth with spreading of 
tumor cells into the leptomeningeal space along the neuroaxis early in the course of the 
disease. Extraneural metastases are rare but frequently lethal, occurring only in 1 to 5% 
of patients, and are related, in the most of cases, to the presence of ventriculoperitoneal 
shunt. Here we characterize the clinical profile of five cases of medulloblastoma with 
systemic spreading of tumor cells, also comparing them to cases already described in 
the literature.
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Mestástases extraneurais em moduloblastoma
RESUMO
O meduloblastoma é o tumor maligno mais frequente do sistema nervoso central na 
infância, mas também pode ocorrer em adultos. Ele apresenta crescimento altamente 
invasivo com disseminação de células tumorais ao longo do neuroeixo precocemente no 
curso da doença. Metástases extraneurais são raras mas frequentemente letais, ocorrendo 
apenas em 1 a 5% dos pacientes, e estão relacionadas, na maioria dos casos, a presença 
de derivação ventriculperitoneal. Neste artigo ,apresentamos o perfil de cinco casos de 
meduloblastoma com disseminção sistêmica das células tumorais, comparando-os com 
os casos já descritos na literatura.
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Medulloblastoma is the most frequent 
malignant tumor of the central nervous 
system (CNS) in children, but it can also 
occur in adults. It is usually restricted to 
the CNS, and its metastases often occur 
along the neuroaxis.The systemic (extra-
neural) medulloblastoma metastases are 
rare, severe and related with a very poor 
prognosis. We report five patients with 
extraneural metastases of medulloblas-
toma, followed in our hospital during the 
period from 1996 to 2009. 
METHOD
Along the last 13 years, we have fol-
lowed-up five patients (5%) with systemic 
metastasis among 96 patients with medul-
loblastoma. There were 2 children and 3 
adults (ages between 2 and 30). Three of 
them presented the tumor located at cere-
bellar vermis, and two at cerebellar hemi-
sphere. The histological subtypes were 
classic in 3 cases, and desmoplastic in 2 
cases. The children had bone marrow me-
tastasis only, while the adults had several 
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organs compromised. Interestingly, only one out five pa-
tients did not present hydrocephalus, consequently had 
no demand of ventriculoperitoneal (VP) shunt, and pre-
sented the longer interval between surgery and detec-
tion of extraneural metastasis (38 months). The adult 
patients that have developed abdominal metastasis had 
previously undergone a VP shunt procedure. However, 
the children did not have abdominal metastasis despite 
the VP shunt. No relation between age, histological types 
and target organs was established due to the restricted 
number of studied cases. Concerning the natural history 
of the disease, the time between the initial symptoms of 
the CNS disease and the onset of the metastasis ranged 
from 6 to 38 months, and all of them received a standard 
treatment: surgical tumor resection and adjuvant treat-
ment. They have in common the short survival after the 
metastases were identified, despite of proper treatment. 
The details of the clinical profile of these five patients 
are presented on Table 1. 
DISCUSSION 
The medulloblastoma metastases usually occur along 
the spinal cord, following the cerebrospinal outflow, or 
along the ventricular system, where it can implant, soak 
and grow1. Extraneural metastases, however, are rare2-4, 
and there are about 119 patients with extraneural me-
dulloblastoma metastases previously described in the 
literature5. The peculiarities of the brain blood barrier 
and the differences between the CNS and the systemic 
environment may explain the rarity of this occurrence. 
The blood brain barrier represents an obstacle for the 
tumoral clones, making difficult their mobility. The sys-
temic environment, in its turn, may not offer the ideal 
conditions to a medulloblastoma clone to implant, soak 
and grow. Even with this scenario, medulloblastoma, 
among all pediatric CNS tumors, has the greatest po-
tential for extraneural spread6. There are few theories 
to explain this phenomenon. Fiorilli et al.7 in 2008 de-
scribed some medulloblastoma molecular features that 
can help our understanding in this matter. He described 
increased expression levels of integrins and tenascins in 
the medulloblatoma cells. Integrin mediates adhesion of 
medulloblastoma cells associated to tenascin, which is 
expressed in the extracellular matrix, and activate path-
ways associated with cell survival and proliferation. This 
interaction may be able to guarantee proliferation and 
adhesion of tumor cells at remote sites, as in neuroaxis, 
and even out of CNS. In the following year, Osawa et al.8 
described that in addition to other cytoskeletal proteins, 
ezrin plays an important role in medulloblastoma adhe-
sion, migration, and invasion; reassuring the idea of the 
great metastatic potential of medulloblastoma .
Previous studies9,10 report that the systemic metas-
tases can occur from 3 to 5% of the medulloblastoma 
population, but there is a lack of reports concerning 
some aspects of the disease, as histological type, tumor 
topography and survival rate. These blanks in the details 
of patients with systemic metastasis of medulloblastoma 
leave incomplete the clinical profile or the natural history 
of this severe condition. The present report of five cases 
and the review of previously reported cases have the aim 
to try to fulfill this gap. Summarized characteristics of 
the previously reported cases are presented on Table 2.
The majority of the previous reports described fewer 
patients, with the exception of the publications of Eb-
erhart (with emphasis in pathological aspects), Camp-
bell (including gliomas in the casuistic) and Mazloom, 
who performed a review of the literature and established 
prognostic factors to patients with extraneural metas-
tasis, as CNS recurrence and radiotherapy. However, no 
Table 1. Clinical findings of the five patients presenting extraneural metastases of medulloblastoma.
Case 1 2 3 4 5
Age at neurosurgery 2 30 29 30 7
Gender M F F M M
Tumor topography vermis hemispheric vermian hemispheric vermis
Hydrocephalus/shunt +/+ +/+ +/+ –/– +/+
Morphological diagnosis classic desmoplastic desmoplastic classic classic
Overall survival (months) 12 18 22 45 9
Time to recurrence or 
metastasis (months)
8 12 18 38 6
Site of metastasis bone marrow abdomen 
and pelvis
peritoneum, 
lungs, bones and 
lymph nodes
bone marrow, 
bones, lymph 
nodes
bone marrow
Cause of death severe anemia 
and sepsis
renal failure ventilatory 
failure
severe anemia 
and sepsis
sepsis
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predictive factors to extraneural metastases development 
were yet identified. Presence of VP shunt has been de-
scribed as a risk factor to this condition by others11,21,26,27, 
especially to bone marrow16, bones28, abdomen19,22,26,27, 
and lymph nodes13,29,30. Extraneural metastasis in me-
dulloblastoma is usually considered as a late-stage com-
plication in the natural history of the disease, however, 
in our series two patients presented extraneural metas-
tasis within one year from the surgical resection of the 
primary tumor. 
A meta-analysis of the data concerning extraneural 
metastasis of medulloblastoma, including our findings, 
allow us to conclude that: [1] the most common sites of 
metastasis are bone marrow and bones, followed by peri-
toneum, lungs and liver, [2] systemic metastasis of me-
dulloblastoma is a rare condition, [3] metastasis aggra-
vates the natural history of the primary condition, and 
[4] it is a factor that worsen the prognosis. 
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